Keyphrases
Airway
100%
Nine-level
100%
Recurrent Wheeze
100%
Azithromycin
100%
Matrix metalloproteinase-9 (MMP-9)
100%
Respiratory Syncytial Virus Bronchiolitis
100%
Upper Airway
45%
Day 14
36%
Wheezing
18%
Respiratory Syncytial Virus
18%
Treatment Group
9%
Non-associated
9%
Placebo
9%
Clinical Trials
9%
Interleukin-8
9%
Significant Risk Factors
9%
Trial Registration
9%
Change from Baseline
9%
Double-blind Placebo-controlled Trial
9%
Childhood Asthma
9%
Clinical Benefit
9%
Anti-inflammatory Effect
9%
Level Reduction
9%
Child Hospitalized
9%
Interleukin (IL)-8
9%
Nasal Lavage
9%
Medicine and Dentistry
Wheeze
100%
Azithromycin
100%
Gelatinase B
100%
Bronchiolitis
100%
Human Respiratory Syncytial Virus
100%
Placebo
18%
Cytokine
9%
In Vitro
9%
Clinical Trial
9%
Asthma
9%
Antiinflammatory Activity
9%
Nasal Irrigation
9%
Treatment Group
9%
Pharmacology, Toxicology and Pharmaceutical Science
Azithromycin
100%
Wheezing
100%
Gelatinase B
100%
Bronchiolitis
100%
Human Respiratory Syncytial Virus
100%
Placebo
18%
Asthma
9%
Clinical Trial
9%
Cytokine
9%
Antiinflammatory Activity
9%
Treatment Group
9%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Bronchiolitis
100%
Airway
100%
Interleukin 8
22%
Cytokine
11%
Asthma
11%
Antiinflammatory Activity
11%
Biochemistry, Genetics and Molecular Biology
Human Respiratory Syncytial Virus
100%
Gelatinase B
100%
MMP9
100%
Interleukin 8
18%
Cytokine
9%
Clinical Trial
9%
In Vivo Study
9%
Antiinflammatory Activity
9%